Lipodystrophy Syndrome in HIV
Seiten
2012
|
Softcover reprint of the original 1st ed. 2003
Springer-Verlag New York Inc.
978-1-4613-5093-4 (ISBN)
Springer-Verlag New York Inc.
978-1-4613-5093-4 (ISBN)
The evolution ofdata about the HIV-Associated Lipodystrophy Syndrome has been rapid. We also believe that the reader of this volume will be able to confront the emerging literature on the HIV-associated lipodystrophy syndrome with a critical eye and that the volume will provide a context in which to place additional data as they are published.
The evolution ofdata about the HIV-Associated Lipodystrophy Syndrome has been rapid. The syndrome itself is complex and controversial. Although great progress has been made in understanding epidemiology and etiology of the syndrome, much about the syndrome remains mysterious. It was our intention to assist HIV providers with a framework for understanding the status and complexities ofthe field. Each author was requested to provide an evidence-based discussion of a topic for which they have expertise. While it is impossible that such a volume be completely comprehensive, we believe that the approach of this book will allow the reader to develop a relatively complete snapshot of the syndrome. We also believe that the reader of this volume will be able to confront the emerging literature on the HIV-associated lipodystrophy syndrome with a critical eye and that the volume will provide a context in which to place additional data as they are published.
The evolution ofdata about the HIV-Associated Lipodystrophy Syndrome has been rapid. The syndrome itself is complex and controversial. Although great progress has been made in understanding epidemiology and etiology of the syndrome, much about the syndrome remains mysterious. It was our intention to assist HIV providers with a framework for understanding the status and complexities ofthe field. Each author was requested to provide an evidence-based discussion of a topic for which they have expertise. While it is impossible that such a volume be completely comprehensive, we believe that the approach of this book will allow the reader to develop a relatively complete snapshot of the syndrome. We also believe that the reader of this volume will be able to confront the emerging literature on the HIV-associated lipodystrophy syndrome with a critical eye and that the volume will provide a context in which to place additional data as they are published.
I Introduction.- II Epidemiology of Fat Redistribution in HIV.- III Body Composition in HIV Lipodystrophy.- IV Methods for Assessing Body Composition in HIV-Associated Lipodystrophy.- V Abnormalities in Glucose and Insulin in HIV Disease.- VI Abnormalities in Lipid Metabolism in HIV.- VII Pathogenesis of HIV Lipodystrophy.- VIII Nutrition and Metabolism in HIV-1-Infected Children Receiving HAART Therapy.- IX Treatment of Hyperlipidemia and Insulin Resistance with Diet.- X Potential Therapies for the HIV-Associated Lipodystrophy Syndrome.
| Zusatzinfo | XI, 233 p. |
|---|---|
| Verlagsort | New York, NY |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Diabetologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin | |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| ISBN-10 | 1-4613-5093-X / 146135093X |
| ISBN-13 | 978-1-4613-5093-4 / 9781461350934 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 75,60
Vol. 1 & 2
Buch | Hardcover (2022)
McGraw-Hill Companies (Verlag)
CHF 284,90
